On Feb. 14, 2018, Sari Kaufman was a 15 year old high school student at Marjory Stoneman Douglas High School in Parkland, Florida, when a gunman opened fire and killed 17 people, a majority of…
First transgender nominee deflects inflammatory questions from GOP…
At a historic hearing Thursday, Rachel Levine, President Joe Biden's nominee for assistant secretary of health at the Department of Health and Human Services, and the first openly transgender person nominated for federal office, told…
House passes bill that would prohibit discrimination against…
The House on Thursday passed the Equality Act, a top agenda item for President Joe Biden that would prohibit discrimination against LGBTQ Americans in a 224-206 vote. Three Republicans voted with all Democrats on the…
What the latest Johnson & Johnson COVID vaccine…
Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…
US refugee agency for children at risk of…
The federal agency tasked with connecting unaccompanied children to relatives or sponsors in the U.S., is on the verge of maxing out its capacity to hold children before they are resettled, new government data shows.…
What the latest Johnson & Johnson COVID vaccine…
Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…
What the latest Johnson & Johnson COVID vaccine…
Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…
What the latest Johnson & Johnson COVID vaccine…
Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…
What the latest Johnson & Johnson COVID vaccine…
Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…